Deal Note: Gibson Dunn Represents Apria Healthcare in Its Sale to The Blackstone Group

October 29, 2008

Gibson, Dunn & Crutcher LLP’s Health Care and Life Sciences Group is pleased to announce its representation of Apria Healthcare Group Inc. in connection with the company’s successful sale to The Blackstone Group, a leading investment and advisory services firm.  The cash transaction, which closed yesterday, is valued at approximately $1.7 billion.

Gibson Dunn’s team was led by Jeffrey Le Sage, a partner in the firm’s Corporate Transactions and Health Care and Life Sciences Practice Groups, and includes Andrew Bogen, Candice Choh, Kristin Blazewicz and Joelle Khoury on corporate, Jeff Hudson, Scott Jacobs and Stacia Neeley on finance, Dora Arash on tax, Sean Feller on benefits and Wayne Smith, Robert Palmer and Matthew Lilly on litigation.

Details of this transaction are available on the Apria Healthcare website.

Gibson Dunn’s Health Care and Life Sciences Group represents a broad array of companies involved in health care and the life sciences, including hospital and nursing home operators, pharmaceutical companies, medical device manufacturers, payors, and biotechnology companies, as well as investors in and advisors to such companies. Our corporate and transactional lawyers assist clients in connection with domestic and international public and private mergers and acquisitions, financings, securities offerings, corporate governance, licensing, development and distributorship arrangements, among other transactions.

For additional information on this transaction, please contact the Gibson Dunn attorney with whom you work, Jeffrey Le Sage (213-229-7504, [email protected]) in Gibson Dunn’s Los Angeles office, or any member of the firm’s Health Care and Life Sciences Practice Group.

© 2008 Gibson, Dunn & Crutcher LLP

Attorney Advertising: The enclosed materials have been prepared for general informational purposes only and are not intended as legal advice.